PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 3, 1999Circulation126 citations

Initial Experience With Larger Laser Sheaths for the Removal of Transvenous Pacemaker and Implantable Defibrillator Leads

View Full Paper
LELaurence M. EpsteinCBCHARLES L. BYRDBWBruce L. Wilkoff

Key Result

Extraction of pacemaker and defibrillator leads using 14F and 16F laser sheaths achieved clinical success in 91-92% of cases with a 3.6% complication rate, comparable to the 12F sheath.

Study Design

Type

Observational (n=863)

Multicenter

Yes

Structured PICO

Do 14F and 16F laser sheaths safely and effectively remove transvenous pacemaker and defibrillator leads compared to the 12F laser sheath in patients requiring lead extraction?

P
Population
863 patients undergoing extraction of 1,285 transvenous pacemaker and implantable defibrillator leads across 52 sites.
E
Exposure
14F and 16F laser sheaths
C
Comparator
12F laser sheath
O
Outcome
Clinical success (extracting the entire lead or the lead body minus the distal electrode) and safety (complications and perioperative mortality)safety

Larger 14F and 16F laser sheaths are as safe and effective as the 12F sheath for the extraction of transvenous pacemaker and defibrillator leads.

Abstract

BACKGROUND: In a previous randomized trial, the 12F laser sheath removed pacing leads via the implant vein more successfully than traditional mechanical tools alone. Two larger sizes of laser sheath, the 14F and 16F models, were developed to extract defibrillator leads and large-diameter pacing leads implanted for the chronic. These devices use pulsed ultraviolet laser light to core though fibrotic tissue grown over the lead body to free the lead from the vasculature. A mandatory prospective registry studied the safety and effectiveness profiles of the larger laser sheaths vis-à-vis the 12F laser sheath. METHODS AND RESULTS: In this study, 863 patients underwent extraction of 1285 leads at 52 sites. Patients treated with the 14F device tended to have older leads than the 12F population; the 16F population, which comprised mostly defibrillator patients, were younger, had younger leads, and were more often male than the 12F population. Clinical success (extracting the entire lead or the lead body minus the distal electrode) was observed in 91% to 92% of cases for all device sizes. The overall complication rate was 3.6%, with 0.8% perioperative mortality. Incidence of complications was independent of laser sheath size. CONCLUSIONS: The 14F and 16F laser sheaths offer an extraction option for larger long-term transvenous pacemaker and defibrillator leads that is as safe and effective as the 12F laser sheath.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Epstein et al. (1999) conducted an observational in Transvenous pacemaker and implantable defibrillator lead extraction (n=863). 14F and 16F laser sheaths vs. 12F laser sheath was evaluated on Clinical success (extracting the entire lead or the lead body minus the distal electrode). Extraction of pacemaker and defibrillator leads using 14F and 16F laser sheaths achieved clinical success in 91-92% of cases with a 3.6% complication rate, comparable to the 12F sheath.

synapsesocial.com/papers/6a3b1faacc8dbc104a21bc8bhttps://doi.org/10.1161/01.cir.100.5.516
Ask AI
Helpful
Bookmark
Share
View Full Paper